「outcomes」の検索結果

Route agent work through AccInt's MCP memory loop: retrieve prior outcomes, resolve frames, and close commitments with evidence.

日本語の概要は準備中です。原文の説明を表示しています。

Conversational AI-first interface with minimal controls, clear outcomes, and delegated task flows for agentic workflows.

日本語の概要は準備中です。原文の説明を表示しています。

Design traceable API checks for contracts, authentication, authorization, errors, and idempotency with observable outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Create an approval-gated product requirements document or decompose an approved PRD into a traceable roadmap. Use for product-level problems, new initiatives, multi-feature scope, PRDs, release outcomes, or roadmap planning.

日本語の概要は準備中です。原文の説明を表示しています。

Capture durable project memory from work, debates, debugging discoveries, learned conventions, deferred options, and session outcomes. Load when the user says remember this, save this learning, record what happened, update project memory, or preserve context for future agents.

日本語の概要は準備中です。原文の説明を表示しています。

Select alternative execution paths when a plan step fails — branch on outcomes instead of blind retry. Load when a structured plan step fails, an unexpected observation arrives, or the user asks what to try next after an error. Also triggers on "try another approach", "route around this failure", "replan on failure", "if X fails try Y", or outcome-based branching during multi-step work. Pairs with structured-planning and debug-and-fix. Does not replace root-cause debugging — adds plan-level path selection.

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

日本語の概要は準備中です。原文の説明を表示しています。

Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Predicts whether a DNA variant alters mRNA splicing using sequence-based deep-learning tools — SpliceAI (10kb context dilated CNN, clinical default), Pangolin (multi-tissue), MMSplice (modular per-region CNN with calibrated ΔPSI), SpliceTransformer/TrASPr (tissue-aware transformers), SpliceVault (empirical 300K-RNA lookup of likely mis-splicing outcomes), CADD-Splice (composite score). Applies the ClinGen SVI 2023 framework for ACMG/AMP variant interpretation (PVS1, PP3, BP4 evidence codes), HGVS splicing nomenclature (c.123+1G>A, c.123-3T>G, r.spl?), extended-window scoring for deep-intronic pseudoexons, tissue-specific predictions, branchpoint variant detection (BPHunter, LaBranchoR), and splice-switching ASO design. Use when interpreting splice impact of clinical variants, prioritizing VUS, identifying deep-intronic pathogenic variants, or designing ASOs.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to set proper expectations on how a DataQ challenge is actually reviewed. Covers state vs federal authority, typical timelines, and common review outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when the user asks how to design or improve a fleet safety scorecard — what KPIs to track, how to weight them, telematics signals vs document compliance vs roadside outcomes, monthly cadence, driver-facing vs admin-facing dashboards, gamification considerations, peer-comparison metrics, and how a scorecard ties to insurance premiums + retention. Reference SMS Methodology v3.20 for industry-standard weights.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when the user asks about accident claims management — first-notice-of-loss procedures, working with insurance adjusters, claim severity classification, subrogation, claim closure timelines, and how to influence claim outcomes. Different from accident-investigation-playbook (which covers facts); this covers the insurance + claim side.

日本語の概要は準備中です。原文の説明を表示しています。

Retrieve and analyze simulation results from a Coval run. Use when user wants to review evaluation outcomes or debug agent behavior.

日本語の概要は準備中です。原文の説明を表示しています。

Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis.

日本語の概要は準備中です。原文の説明を表示しています。

AEO — Agent 效果运营平台。自动发现 Agent 效果漂移、诊断根因、运行 AI 数据闭环工具链，给出 AI 效果优化方案。Measure agent performance, attribute outcomes, track quality trends, optimize cost, and monitor SLAs.

日本語の概要は準備中です。原文の説明を表示しています。

Generate a session report with token usage estimates, work summary, and outcomes

日本語の概要は準備中です。原文の説明を表示しています。

Decision tree analysis for complex decision-making across all domains. Use when user needs to evaluate multiple options with uncertain outcomes, assess risk/reward scenarios, or structure choices systematically. Applicable to business, investment, personal decisions, operations, career choices, product strategy, and any situation requiring structured evaluation. Triggers include decision tree, should I, what if, evaluate options, compare alternatives, risk analysis.

日本語の概要は準備中です。原文の説明を表示しています。

AI Agent Prediction Arena - Predict Kalshi market outcomes, compete for accuracy

日本語の概要は準備中です。原文の説明を表示しています。

Audit or design server-side indexes, directories, reputations, or aggregates that are DERIVED from traffic a platform witnesses (chain heads, run verdicts, heartbeats, publish activity) so that consent gates the derivation, not merely the read: no shadow index over non-consenting principals, post-consent-only evidence windows, retention bounds and delete-propagation into derived rows, activity-oracle threat modeling, and audit-logged ranking discretion. Use when building a capability directory / whois from witnessed activity, a reputation ledger from settled outcomes, vitals aggregation across tenants, or any "the yellow pages can't lie because they index signatures" feature. Keywords: shadow index, derived index, consent gates derivation, activity oracle, phone book not a log, delist propagation, ranking weight audit, k-anonymous aggregate, subpoena surface. NOT for the consent-screen UX and scope-ladder mechanics themselves (use local-first-tenancy-boundary), reputation scoring math and Sybil economics (use agent-identity-continuity-reputation), or discovery-layer architecture L1/L2/L3 (use agent-discovery-directories-guilds).

日本語の概要は準備中です。原文の説明を表示しています。

Design or audit an agent identity, credential, session, continuity, and reputation plan. Use when attributed outcomes must survive key rotation, restart, recovery, or review; when choosing Elo, TrueSkill, a contextual bandit, or an LLM judge; and when making Sybil, newcomer, calibration, collusion, and evidence limits explicit. Produces a supplied-plan consistency audit, never proof of observed delivery, cryptographic identity, or live enforcement. NOT for proving personhood, global Sybil resistance, or an unobserved delivery.

日本語の概要は準備中です。原文の説明を表示しています。